BE904831A - Composition d'activateur tissulaire du plasminogene. - Google Patents

Composition d'activateur tissulaire du plasminogene.

Info

Publication number
BE904831A
BE904831A BE0/216712A BE216712A BE904831A BE 904831 A BE904831 A BE 904831A BE 0/216712 A BE0/216712 A BE 0/216712A BE 216712 A BE216712 A BE 216712A BE 904831 A BE904831 A BE 904831A
Authority
BE
Belgium
Prior art keywords
amino acid
activator composition
tissue activator
plasminogen tissue
acid sequence
Prior art date
Application number
BE0/216712A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858513358A external-priority patent/GB8513358D0/en
Priority claimed from GB858521704A external-priority patent/GB8521704D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of BE904831A publication Critical patent/BE904831A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Solution aqueuse parentérale d'un pH de 2 à 5 contenant du t-PA mono- ou bicaténaire qui a la séquence des aminoacides à laFig. 1 ou a la meme séquence des aminoacides, mais dont l'aminoacide à la position 245 à partir de l'extrémité N-terminale de la sérine est la valine au lieu de la méthionine, l'une ou l'autre séquence étant éventuellement exempte de l'un quelconque des trois premiers aminoacides ou comprenant éventuellement une préséquence de Gly-Ala-Arg supplémentaire N-terminale du polypeptide.
BE0/216712A 1985-05-28 1986-05-27 Composition d'activateur tissulaire du plasminogene. BE904831A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation
GB858521704A GB8521704D0 (en) 1985-08-31 1985-08-31 Formulation

Publications (1)

Publication Number Publication Date
BE904831A true BE904831A (fr) 1986-11-27

Family

ID=26289289

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216712A BE904831A (fr) 1985-05-28 1986-05-27 Composition d'activateur tissulaire du plasminogene.

Country Status (22)

Country Link
US (1) US5112609A (fr)
AT (1) AT391812B (fr)
AU (1) AU569429B2 (fr)
BE (1) BE904831A (fr)
CA (1) CA1297008C (fr)
CH (1) CH664495A5 (fr)
DE (1) DE3617753A1 (fr)
DK (1) DK163174C (fr)
ES (1) ES8706443A1 (fr)
FI (1) FI85334C (fr)
FR (1) FR2593393B1 (fr)
GB (1) GB2176703B (fr)
GR (1) GR861365B (fr)
HU (1) HU200695B (fr)
IL (1) IL78937A (fr)
IT (1) IT1191925B (fr)
LU (1) LU86445A1 (fr)
NL (1) NL8601354A (fr)
NO (1) NO171344C (fr)
NZ (1) NZ216306A (fr)
PT (1) PT82647B (fr)
SE (1) SE462893B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185259A (en) * 1982-05-05 1993-02-09 Genentech, Inc. Truncated human tissue plasminogen activator
FI831484L (fi) * 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
GT198302091A (es) * 1982-05-05 1984-10-25 Activador de plasminogeno de tejido humano a),b),c).
HUT41632A (en) * 1985-03-06 1987-05-28 Survival Technology Process for preparing agents for the enhancement of protein absorption
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
LU86875A1 (fr) * 1986-05-12 1988-01-20 Wellcome Found Utilisation de l'activateur tissulaire du plasminogene,son association avec une superoxyde-dismutase et formulation pharmaceutique contenant cette association
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments
WO1990001334A1 (fr) * 1988-08-05 1990-02-22 Codon Formules d'activateur du plasminogene a base d'aspartate
GB8819607D0 (en) * 1988-08-17 1988-09-21 Wellcome Found Novel combination
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
GB9000629D0 (en) * 1990-01-11 1990-03-14 Porton Prod Ltd Tissue plasminogen activator
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
EP0827751B1 (fr) * 1996-09-06 2003-02-26 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Composition médicinale qui contient de l'activateur de plasminogène tissulaire et de la nicotinamide
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US20030077682A1 (en) * 2001-09-07 2003-04-24 Hung Paul Porwen Human tissue urokinase type plasminogen activator formulation
CA2726908C (fr) * 2008-06-04 2017-01-24 Talecris Biotherapeutics, Inc. Composition, methode et necessaire pour la preparation de plasmine
JP5789521B2 (ja) 2009-03-03 2015-10-07 グリフオルス・セラピユーテイクス・インコーポレーテツドＧｒｉｆｏｌｓ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． プラスミノーゲンを製造するための組成物、方法およびキット；ならびにそれから製造されるプラスミン

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
FR2252842B1 (fr) * 1973-12-03 1977-11-04 Fabre Sa Pierre
DE3015699C2 (de) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Herstellung eines Plasminogen-Aktivators
CA1154671A (fr) * 1979-07-27 1983-10-04 Lucien D. D'hinterland Separation d'un activateur tissulaire du plasminogene
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
NL191755C (nl) * 1982-10-29 1996-07-02 Mitsui Toatsu Chemicals Plasminogeenactivator en trombolytisch middel.
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
DE3382389D1 (de) * 1982-12-14 1991-10-02 South African Inventions Plasminogenaktivator.
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
EP0156169B1 (fr) * 1984-02-29 1991-12-18 Asahi Kasei Kogyo Kabushiki Kaisha Solution aqueuse d'un activateur tissulaire du plasminogène dissous à une concentration élevée et un procédé d'obtention
DE3439980A1 (de) * 1984-11-02 1986-05-07 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung sowie pasteurisierung von urokinase
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
EP0417662B1 (fr) * 1989-09-13 1995-12-13 Maschinenfabrik Rieter Ag Procédé pour commencer le cycle de travail d'un chariot de surveillance dans une machine textile

Also Published As

Publication number Publication date
NO171344B (no) 1992-11-23
DK163174B (da) 1992-02-03
AT391812B (de) 1990-12-10
NL8601354A (nl) 1986-12-16
NO862095L (no) 1986-12-01
GR861365B (en) 1986-09-29
HU200695B (en) 1990-08-28
FI85334C (fi) 1992-04-10
FI862226A0 (fi) 1986-05-27
IT1191925B (it) 1988-03-31
FR2593393B1 (fr) 1989-06-02
DK163174C (da) 1992-06-22
ATA141186A (de) 1990-06-15
DK246886D0 (da) 1986-05-27
LU86445A1 (fr) 1986-12-05
FI85334B (fi) 1991-12-31
AU5796586A (en) 1986-12-04
FR2593393A1 (fr) 1987-07-31
SE8602404L (sv) 1986-11-29
US5112609A (en) 1992-05-12
GB2176703A (en) 1987-01-07
GB2176703B (en) 1988-12-07
HUT42330A (en) 1987-07-28
SE8602404D0 (sv) 1986-05-27
IL78937A (en) 1990-11-29
GB8612781D0 (en) 1986-07-02
DK246886A (da) 1986-11-29
AU569429B2 (en) 1988-01-28
IL78937A0 (en) 1986-09-30
PT82647A (en) 1986-06-01
FI862226A (fi) 1986-11-29
DE3617753C2 (fr) 1988-06-30
DE3617753A1 (de) 1986-12-04
PT82647B (pt) 1989-01-30
ES8706443A1 (es) 1987-07-01
NZ216306A (en) 1989-10-27
NO171344C (no) 1993-03-03
ES555352A0 (es) 1987-07-01
SE462893B (sv) 1990-09-17
CH664495A5 (de) 1988-03-15
CA1297008C (fr) 1992-03-10
IT8648064A0 (it) 1986-05-27

Similar Documents

Publication Publication Date Title
BE904831A (fr) Composition d'activateur tissulaire du plasminogene.
US4530787B1 (fr)
ES2196031T3 (es) Derivados peptidicos terapeutico.
ES2125718T3 (es) Purificacion de corriente de subproducto en la preparacion de poliesteres a base de 1,3-propanodiol.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
KR870006188A (ko) 과립구 대식세포 콜로니 촉진 인자(gm-csf) 단백질의 제조방법
LV12000A (lv) Olbaltumviela ar uratoksidazes aktivitati un tas iegusana
SE8901552D0 (sv) Acid addition salts of amidated or glycine, their preparation and use
DK0639202T3 (da) Stabil polypeptidsammensætning
EP0326490A3 (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
ZA823339B (en) Purification or enrichment of biologically active proteins and agent therefor
KR950005325A (ko) 제약 조성물
EA200001252A1 (ru) КОМПОЗИЦИЯ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА-β-1A(IFN-β-1A) ЧЕЛОВЕКА
ATE93731T1 (de) Protein enthaltende waesserige loesungen.
AU637997B2 (en) Pentamidine solutions for preventing pneumocystis carinii pneumonia
PT84011A (fr) Procede de preparation de nouveaux analogues de composes polypeptidiques hypocalcemiants epargnant de calcium de l:organisme
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
KR970006314A (ko) 항균성 및 항진균성 활성을 갖는 폴리펩타이드
SU1290679A1 (ru) (n,n'-бисдиэтаноламинометилен)диамиды карбоновых кислот в качестве дубителей и пластификаторов фотографических желатиновых галогенсеребряных слоев
DK661888A (da) Biologisk aktive molekyler
KR950032619A (ko) 변형된 인간 적혈구 성장 촉진 인자 유전자 및 그의 발현벡터

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE WELLCOME FOUNDATION LTD

Effective date: 19950531